Mucoadhesive Chitosan-Dextran Sulfate Nanoparticles for Sustained Drug Delivery to the Ocular Surface

被引:65
作者
Chaiyasan, Wanachat [1 ,2 ]
Srinivas, Sangly P. [3 ]
Tiyaboonchai, Waree [1 ,2 ]
机构
[1] Naresuan Univ, Fac Pharmaceut Sci, Dept Pharmaceut Technol, Phitsanulok 65000, Thailand
[2] Naresuan Univ, Ctr Excellence Innovat Chem, Phitsanulok 65000, Thailand
[3] Indiana Univ, Sch Optometry, Bloomington, IN USA
关键词
DRY EYE; LUBRICANT; EFFICACY; BIOAVAILABILITY; FORMULATION; POLYMERS; INSULIN; SYSTEMS; CORNEAL; AGENT;
D O I
10.1089/jop.2012.0193
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To characterize nanoparticles produced by self-assembly of oppositely charged polymers, cationic chitosan (CS), and anionic dextran sulfate (DS), for drug delivery to the ocular surface. The goal is to overcome the short residence time of topical drugs through their sustained release from mucoadhesive nanoparticles. Methods: Chitosan-dextran sulfate nanoparticles (CDNs) were produced by mixing CS and DS; polyethylene glycol-400 was used as a surface stabilizing agent. Fourier transform infrared spectroscopy (FTIR) spectra of CS, DS, and CDNs were determined in the wavenumber range of 4,000-700 cm(-1) to assess the ionic interactions in the formation of CDNs. The physicochemical properties, entrapment efficacy, and dissolution profile of CDNs were investigated using Rhodamine B (RhB) and Nile Red (NR) as drug analogs. The mucoadhesiveness of the CDNs was assessed by imaging the retention of the fluorescein isothiocyanate-labeled CDNs on the cornea ex vivo, which was subjected to shear stress by a steady stream of saline solution. Results: CDNs were obtained by the polyelectrolyte complexation technique. The FTIR spectra of CDNs showed spectral shifts in the amine and sulfate regions, confirming an involvement of electrostatic interactions between cationic CS and anionic DS. The CDNs were spherical in shape and segregated. They possessed a particle size of similar to 400 nm with a polydispersity index of 0.3 and exhibited a zeta potential of similar to 40 mV. A high entrapment efficacy of up to 80% was observed with both RhB and NR. In the dissolution experiments, NR was released from CDNs within 60 min, but RhB was not released. This indicates that the release of drugs could depend on their molecular interactions with the particle. Exposure of CDNs to lysozyme, which is found in tears, had no effect on the mean particle size or the surface charge. Instillation of NR, RhB, and FITC in the presence of saline irrigation resulted in their rapid disappearance (<5 min) from the corneal surface. In contrast, fluorescent CDNs showed retention on the cornea even after 60 min. Conclusions: Cationic and biocompatible mucoadhesive CDNs have been developed for sustained drug delivery to the ocular surface. The CDNs were stable to lysozyme and showed prolonged adherence to the corneal surface.
引用
收藏
页码:200 / 207
页数:8
相关论文
共 37 条
[1]   Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: In vitro and pharmacokinetics studies [J].
Bhatta, R. S. ;
Chandasana, H. ;
Chhonker, Y. S. ;
Rathi, C. ;
Kumar, D. ;
Mitra, K. ;
Shukla, P. K. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 432 (1-2) :105-112
[2]   Mucoadhesive Microdiscs Engineered for Ophthalmic Drug Delivery: Effect of Particle Geometry and Formulation on Preocular Residence Time [J].
Bin Choy, Young ;
Park, Jung-Hwan ;
McCarey, Bernard E. ;
Edelhauser, Henry F. ;
Prausnitz, Mark R. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (11) :4808-4815
[3]   Mucoadhesive microparticles engineered for ophthalmic drug delivery [J].
Bin Choy, Young ;
Park, Jung-Hwan ;
Prausnitz, Mark R. .
JOURNAL OF PHYSICS AND CHEMISTRY OF SOLIDS, 2008, 69 (5-6) :1533-1536
[4]  
Chen Y, 2007, AAPS PHARMSCITECH, V8
[5]   Chitosan nanoparticle-based neuronal membrane sealing and neuroprotection following acrolein-induced cell injury [J].
Cho Y. ;
Shi R. ;
Ben Borgens R. .
Journal of Biological Engineering, 4 (1)
[6]   Efficacy in Patients with Dry Eye After Treatment with a New Lubricant Eye Drop Formulation [J].
Davitt, William F. ;
Bloomenstein, Marc ;
Christensen, Mike ;
Martin, Anna E. .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 26 (04) :347-353
[7]   Chitosan nanoparticles as new ocular drug delivery systems:: in vitro stability, in vivo fate, and cellular toxicity [J].
de Campos, AM ;
Diebold, Y ;
Carvalho, ELS ;
Sánchez, A ;
Alonso, MJ .
PHARMACEUTICAL RESEARCH, 2004, 21 (05) :803-810
[8]   Applications of nanoparticles in ophthalmology [J].
Diebold, Yolanda ;
Calonge, Margarita .
PROGRESS IN RETINAL AND EYE RESEARCH, 2010, 29 (06) :596-609
[9]   Ocular drug delivery - a look towards nanobioadhesives [J].
du Toit, Lisa C. ;
Pillay, Viness ;
Choonara, Yahya E. ;
Govender, Thirumala ;
Carmichael, Trevor .
EXPERT OPINION ON DRUG DELIVERY, 2011, 8 (01) :71-94
[10]   Clinical evaluation of the efficacy of PEG/PG lubricant eye drops with gelling agent (HP-GUAR) for the relief of the signs and symptoms of dry eye disease: A review [J].
Foulks, Gary N. .
DRUGS OF TODAY, 2007, 43 (12) :887-896